Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

870 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Equivalent biochemical failure-free survival after external beam radiation therapy or radical prostatectomy in patients with a pretreatment prostate specific antigen of > 4-20 ng/ml.
D'Amico AV, Whittington R, Kaplan I, Beard C, Jiroutek M, Malkowicz SB, Wein A, Coleman CN. D'Amico AV, et al. Among authors: kaplan i. Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1053-8. doi: 10.1016/s0360-3016(96)00633-5. Int J Radiat Oncol Biol Phys. 1997. PMID: 9169812 Free article.
Equivalent 5-year bNED in select prostate cancer patients managed with surgery or radiation therapy despite exclusion of the seminal vesicles from the CTV.
D'Amico AV, Whittington R, Kaplan I, Beard C, Schultz D, Malkowicz SB, Tomaszewski JE, Wein A, Coleman CN. D'Amico AV, et al. Among authors: kaplan i. Int J Radiat Oncol Biol Phys. 1997 Sep 1;39(2):335-40. doi: 10.1016/s0360-3016(97)00320-9. Int J Radiat Oncol Biol Phys. 1997. PMID: 9308936 Free article.
The clinical utility of the percent of positive prostate biopsies in predicting biochemical outcome following external-beam radiation therapy for patients with clinically localized prostate cancer.
D'Amico AV, Schultz D, Silver B, Henry L, Hurwitz M, Kaplan I, Beard CJ, Renshaw AA. D'Amico AV, et al. Among authors: kaplan i. Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):679-84. doi: 10.1016/s0360-3016(00)01423-1. Int J Radiat Oncol Biol Phys. 2001. PMID: 11172949
A critical examination of the results from the Harvard-MIT NCT program phase I clinical trial of neutron capture therapy for intracranial disease.
Busse PM, Harling OK, Palmer MR, Kiger WS 3rd, Kaplan J, Kaplan I, Chuang CF, Goorley JT, Riley KJ, Newton TH, Santa Cruz GA, Lu XQ, Zamenhof RG. Busse PM, et al. Among authors: kaplan i, kaplan j. J Neurooncol. 2003 Mar-Apr;62(1-2):111-21. doi: 10.1007/BF02699938. J Neurooncol. 2003. PMID: 12749707 Clinical Trial.
Pooled analysis of stereotactic ablative radiotherapy for primary renal cell carcinoma: A report from the International Radiosurgery Oncology Consortium for Kidney (IROCK).
Siva S, Louie AV, Warner A, Muacevic A, Gandhidasan S, Ponsky L, Ellis R, Kaplan I, Mahadevan A, Chu W, Swaminath A, Onishi H, Teh B, Correa RJ, Lo SS, Staehler M. Siva S, et al. Among authors: kaplan i. Cancer. 2018 Mar 1;124(5):934-942. doi: 10.1002/cncr.31156. Epub 2017 Dec 20. Cancer. 2018. PMID: 29266183 Free article.
The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.
Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S. Correa RJM, et al. Among authors: kaplan i. Eur Urol Focus. 2019 Nov;5(6):958-969. doi: 10.1016/j.euf.2019.06.002. Epub 2019 Jun 24. Eur Urol Focus. 2019. PMID: 31248849
870 results